申请人:Synsorb Biotech, Inc.
公开号:US06087339A1
公开(公告)日:2000-07-11
Disclosed are novel saccharide derivatives which inhibit binding of toxins, such as heat-labile enterotoxin or cholera toxin, to their receptors either in vitro or in vivo. Additionally, disclosed are compounds which inhibit binding of enterovirulent organisms (e.g., bacteria, virus, fungi, and the like), such as Vibrio cholerae and enterotoxigenic strains of Escherichia coli, to their cell surface receptors.
本发明涉及一种新型糖衍生物,其可以在体外或体内抑制毒素(如热敏性肠毒素或霍乱毒素)与其受体的结合。此外,本发明还涉及一种化合物,其可以抑制肠道致病微生物(如细菌、病毒、真菌等)与其细胞表面受体的结合,例如霍乱弧菌和肠毒素原性大肠杆菌菌株。